Skip to content
Medical Learning Institute, Inc.
Medical Learning Institute, Inc.
  • Home
  • About Us
    • About MLI
    • Societies and Partners
    • CE Coordinator Incentive Program (CECIP)
  • Accreditation
    • About MLI Accreditation
    • Joint Providership Request
  • Activities
    • Upcoming Events
    • On-Demand Activities
  • Educational Series
    • Featured Educational Series
      • Targeted Therapy in Atopic Dermatitis Series: A Med Table Talk™
      • CAR T-Cell Therapy in Lymphoma Series: A Med Table Talk™
      • Diabetes Series: Mealtime Insulin
      • Incretins Series: A Med Table Talk™
      • GVHD Series: Interactive Provider Network ECHO Program
      • SOHO 2022
  • A Quick Dose of CE
  • Contact Us
  • Home
  • About Us
    • About MLI
    • Societies and Partners
    • CE Coordinator Incentive Program (CECIP)
  • Accreditation
    • About MLI Accreditation
    • Joint Providership Request
  • Activities
    • Upcoming Events
    • On-Demand Activities
  • Educational Series
    • Featured Educational Series
      • Targeted Therapy in Atopic Dermatitis Series: A Med Table Talk™
      • CAR T-Cell Therapy in Lymphoma Series: A Med Table Talk™
      • Diabetes Series: Mealtime Insulin
      • Incretins Series: A Med Table Talk™
      • GVHD Series: Interactive Provider Network ECHO Program
      • SOHO 2022
  • A Quick Dose of CE
  • Contact Us
Medical Learning Institute, Inc.
Medical Learning Institute, Inc.
  • Home
  • About Us
    • About MLI
    • Societies and Partners
    • CE Coordinator Incentive Program (CECIP)
  • Accreditation
    • About MLI Accreditation
    • Joint Providership Request
  • Activities
    • Upcoming Events
    • On-Demand Activities
  • Educational Series
    • Featured Educational Series
      • Targeted Therapy in Atopic Dermatitis Series: A Med Table Talk™
      • CAR T-Cell Therapy in Lymphoma Series: A Med Table Talk™
      • Diabetes Series: Mealtime Insulin
      • Incretins Series: A Med Table Talk™
      • GVHD Series: Interactive Provider Network ECHO Program
      • SOHO 2022
  • A Quick Dose of CE
  • Contact Us

CPE

Episode 3 of 3 – Help Your Patients Navigate Risk-benefit Assessment, Choose the Best Therapy for Them, and Mitigate TEAEs

Episode 2 of 3 – Moving Towards Fixed-Duration Therapy in CLL and SLL

Episode 1 of 3 – What You MUST Know About the Emerging Standard of Care for 1L Treatment of CLL and SLL

Making the Right Call: Biomarker Testing and Targeting in NSCLC: Part II: Treating Acquired Resistance and Evaluating Next-generation Therapies

Making the Right Call: Biomarker Testing and Targeting in NSCLC: Part I: Equitable, Guideline-based Testing for Prognosis and Treatment

Build Your Own Case Study: A Glimpse at Optimal T2D Management: Enhancing Outcomes with GLP-1 RAs

Transitioning from Chemoimmunotherapy to More Targeted Approaches in MCL

Supporting Our Colleagues: Easing the Burden of Referrals for CAR-T in Aggressive B-cell Lymphomas

Mastering MRD for Prognosis and Treatment in ALL

Personalizing Treatment Options Across the Continuum of MDS and sAML

Posts navigation
1 2 Next Page →

Medical Learning Institute, Inc.
40946 US Highway 19N, #602
Tarpon Springs, FL, 34689
888.654.2631 (toll-free)
609.333.1693 (direct)

Copyright ©2023  Medical Learning Institute, Inc.  All Rights Reserved